This study enrolls people with COVID-19 symptoms and a positive test result for COVID-19 (a free COVID-19 rapid antigen test is available for eligible participants). These symptoms include fever, chills, cough, nasal symptoms, body aches/muscle aches, headache, loss of smell, loss of taste, nausea, vomiting, diarrhea, fatigue, dizziness. The purpose of the study is to learn if a supplement will reduce inflammation and improve immune response in people with COVID-19. Read More
Adults ages 18+.
Females may not be pregnant at the time of enrollment.
Must have symptoms of COVID-19 and a positive test result.
This study enrolls high school students and teachers. The purpose of the study is to help students learn how to culture microbial organisms found in water samples from streams, rivers or lakes, and to teach about genome annotation, DNA sequencing and genomic DNA isolation. The study is also meant to help students learn more about scientific and health-related careers. Read More
Students in Grades 9 – 12 from Allegany, Cattaraugus, Chautauqua, Erie, Genesee, Livingston, Monroe, Niagara, Ontario, Orleans, Steuben, Wayne, Wyoming and Yates counties/schools.
High School Biology (grades 9-12) teachers from Allegany, Cattaraugus, Chautauqua, Erie, Genesee, Livingston, Monroe, Niagara, Ontario, Orleans, Steuben, Wayne, Wyoming and Yates counties/schools.
This study enrolls people who are HIV positive who are taking certain medication. If a person take Stribilid® or Genvoya®, there may be changes in the way their body uses or removes other medications. We want to study another approved treatment, Biktarvy®, that we believe is less likely to affect how the body handles other medications that a person is currently taking. This switch may improve quality of life. Read More
-Adults ages 18+.
-Positive for HIV.
-Taking current antiretroviral therapy GenvoyaTM or StribildTM for HIV-1 infection.
-Taking at least 1 or more other prescription medications.
This study is looking for women ages 18-24 who are in college. The purpose of this study is to get feedback about program designed for friends to help protect one another against sexual assault. Read More
Adult women ages 18-24.
Enrolled in a 4 year college or university
This study enrolls adults with peripheral arterial disease (PAD; blocked arteries in the legs) who are having a lower extremity endovascular intervention (EVI). The purpose of the study is to learn how well a blood test called Plateletcrit find blood clotting cells. We want to see if this test might be useful to learn about outcomes for this surgery. Read More
Adults ages 18+
Have undergone extremity endovascular intervention (EVI) treatment of lower extremity peripheral arterial disease (PAD) or critical limb ischemia
On aspirin at time of the intervention and will receive dual antiplatelet therapy after surgery with aspirin and clopidogrel for at least 30 days.
This study enrolls medical students, residents, and fellow physicians at the University at Buffalo Jacobs School of Medicine and Biomedical Sciences who have a FitBit device. The purpose of this study is to learn what part of sleep health is associated with physician burnout to help decrease damage and improve sleep health. Read More
You are a medical student, resident, or fellow at University at Buffalo
Must have a FitBit device
This study enrolls adults who have a rheumatological condition and are followed by a rheumatologist. The purpose of this study is to compare the COVID-19 status of people who have been taking hydroxychloroquine to those who have not been taking it. Hydroxychloroquine is routinely prescribed for rheumatological conditions. Read More
Adults ages 18+.
Patient follows with an outpatient Rheumatologist